Target intelligence / Profile preview

NMNAT1 pseudogene 2 (NMNAT1P2)

Target
NMNAT1P2
Molecular classification
Other (Pseudogene; not a functional enzyme, receptor, transporter, etc.)
01

Overview

NMNAT1 pseudogene 2 (NMNAT1P2) is a non-coding pseudogene related to the NMNAT1 gene, which encodes nicotinamide nucleotide adenylyltransferase 1, a nuclear enzyme essential for NAD+ synthesis[5]. Pseudogenes like NMNAT1P2 do not encode functional protein products, are not currently considered therapeutic or biological targets, and are not associated with known disease mechanisms or drug actions. NMNAT1 pseudogenes, including NMNAT1P2, may be identified in genomic surveys but have no established biological, diagnostic, or therapeutic roles. The information relevant to human health and disease pertains to the functional NMNAT1 gene, not its pseudogenes[5].

Other names
NMNAT1P2Nicotinamide nucleotide adenylyltransferase 1 pseudogene 2NMNAT1-ps2
02

Mechanism of action

None (No drugs target this pseudogene, so no mechanism of action applies.)

03

Biological functions

None
04

Disease associations

None
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on NMNAT1 pseudogene 2 (NMNAT1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NMNAT1 pseudogene 2 (NMNAT1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call